keynote-811: trastuzumab chemotherapy with or without pembrolizumab for her2 g/gej cancer
Published 3 years ago • 420 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
6:21
pembrolizumab plus trastuzumab and chemotherapy for her2 metastatic gastric or gastroesophageal...
-
1:10
keynote-811: hrqol pembro plus tras and chemo in first-line her2 advanced gastric cancer
-
3:30
keynote-811 update from esmo 2024 - pembrolizumab trastuzumab chemo for her2 gastric or gej
-
1:04
panthera: pembrolizumab, trastuzumab, and chemotherapy in her2 advanced gastric cancer
-
8:01
innovation: chemotherapy with trastuzumab and pertuzumab in her2 gastric cancer
-
4:35
keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
-
3:12
advances in her2-targeted therapies for gastric cancer
-
1:43
gasther2: trastuzumab for advanced gastric cancer
-
7:45
pembrolizumab alone or with chemotherapy for advanced gastric/ge junction cancer
-
1:07:30
personalizing gastric cancer care with her2-targeted and other novel therapies
-
1:08
dr. chung on the rationale of the keynote-811 trial in her2 gastric cancer
-
2:39
first line immunotherapy/chemotherapy in her2- gastric cancer in japan
-
35:36
personalized treatment of advanced her2-negative gastric or gastroesophageal junction cancer
-
0:54
targeted treatment for gastric cancer beyond her2
-
1:39
treatment for her2 metastatic breast cancer
-
3:14
keynote-062 study: pembrolizumab as treatment for advanced gastroesophageal junction and gastric...
-
2:00
matterhorn: neoadjuvant-adjuvant durvalumab and flot chemotherapy in resectable g/gej
-
0:48
current and future directions in gastric cancer research
-
0:47
dr. yee on neoadjuvant pertuzumab in her2-positive breast cancer